Weight Loss Injections During Menopause: What the Evidence Actually Shows

The myth: GLP-1 medicines stop working once oestrogen drops

A common assumption is that the hormonal environment of menopause somehow neutralises the effect of weight loss injections. It is an understandable worry (many women find that approaches which once worked no longer do) but it does not reflect what the clinical evidence shows. Tirzepatide and semaglutide work by acting on gut-hormone receptors (GIP and GLP-1, or GLP-1 alone) that regulate appetite, satiety, and how quickly food moves through the stomach. These mechanisms are not oestrogen-dependent.

The large phase 3 trials did not separate results by menopausal status, so there is no head-to-head dataset comparing pre- and post-menopausal outcomes. What the SURMOUNT-1 trial, published in the New England Journal of Medicine, does show is an average body-weight reduction of around 20–21% at the highest tirzepatide dose over 72 weeks, across a broad adult population. Age was not found to eliminate benefit. The honest answer on menopause specifically: the evidence is promising but not fully stratified, so if this is a deciding factor for you, a prescriber should walk through it with you rather than you relying on a generalised answer.

To check which licensed weight management options exist and how they compare in broad terms, the weight loss injections overview gives a useful starting point.

What menopause actually does to weight, and where injections fit in

Oestrogen decline during perimenopause and menopause changes where the body stores fat, with more accumulating around the abdomen. Metabolic rate slows, lean muscle mass tends to fall, and appetite-regulating hormones shift. Sleep disruption, which is extremely common, compounds this further. None of this is a failure of willpower. It is biology.

GLP-1 receptor agonists address several of these pressures directly: they reduce appetite, slow gastric emptying, and help people feel full on less food. They do not restore oestrogen or reverse the metabolic changes of menopause, so realistic expectations matter. Many women find that combining a licensed injection with the lifestyle support that should accompany treatment (adequate protein, resistance activity, good sleep habits where possible) produces results that diet alone has failed to achieve for years. It is also worth knowing that weight loss injections for men follow a comparable combined approach, which gives a useful point of comparison if you are looking at how outcomes are framed across different groups. The weight loss treatment overview sets out what that combined approach looks like in practice.

For women considering options alongside HRT, one thing worth doing before your consultation is a quick check of your current HRT formulation: patch, gel, or oral tablet. This distinction matters when your prescriber is deciding which injection is most straightforward alongside your existing treatment.

HRT, oral contraceptives, and the absorption question

This is where the clinical detail becomes important. Tirzepatide slows gastric emptying, particularly in the first weeks of treatment and after each dose step. That slowing can reduce how much of an orally taken medicine is absorbed before it moves through the gut. The practical implication: NHS England's guidance on weight management injections advises that women taking tirzepatide should discuss switching to transdermal HRT (a patch or gel applied to the skin) with their doctor, because absorption via the skin bypasses this issue entirely.

For oral contraceptive pills specifically, the guidance is more specific still: women should add a non-oral method of contraception for the first four weeks of tirzepatide treatment and for four weeks after each dose increase. This does not apply in the same way to semaglutide (Wegovy), where there is no equivalent published evidence of reduced pill effectiveness, though that distinction is worth raising in your consultation if you are deciding between the two injections. Some patients also ask whether b12 injections can cause weight loss, particularly if they have heard about b12 as a supplement alongside other treatments, and that page explains clearly where the evidence does and does not support a role for b12 in weight management.

None of this makes tirzepatide the wrong choice; for many women it may still be the better clinical fit. It simply means the conversation with a prescriber needs to cover your full medication list. Our clinical team reviews this routinely. If you want to read about the specific evidence behind tirzepatide as a treatment, the Eli Lilly weight loss injection page covers its development and trial results in detail.

Eligibility, what is still uncertain, and who makes the final call

The licensed eligibility criteria for both Mounjaro and Wegovy are set by the medicines' approvals, not by life stage. For weight management, both are licensed for adults with a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. Menopause-related conditions can themselves count here; your prescriber will assess which apply. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance, this is worth flagging if relevant to you. Details on the full eligibility picture are on the what weight do you need for weight loss injections page.

What remains genuinely uncertain is how much of the weight-loss response in peri- and post-menopausal women is attributable to the injection versus the lifestyle changes that accompany it, and whether outcomes differ meaningfully by hormonal status. Research is ongoing, and if you want a closer look at how one specific injectable option works in practice, the page covering the m injection for weight loss sets out the mechanism, dosing, and what patients can realistically expect. Reporting any unexpected side effects via the MHRA Yellow Card scheme contributes to that evidence base and is something every patient on a newer medicine can do.

These are prescription-only medicines. No website, article, or AI overview can tell you whether they are right for you individually. What a consultation with a prescriber can do is review your weight history, current medications (including HRT), relevant health conditions, and your goals, and reach a considered decision. If you are ready to take that step, you can speak to our prescribers through a free consultation.